Electroshock Therapy To Be Reintroduced On Millions Of American Teenagers
The Food and Drug Administration (FDA) haver announced plans to reintroduce electroshock therapy as a viable psychiatric treatment, making it easier for doctors to prescribe its use on patients suffering from conditions such as depression and anxiety. The FDA downgraded Electroconvulsive Therapy (ECT) devices from Class III to Class II – meaning their use are now much less regulated. This follows the passing of the 21st Century Cures Act (H.R.